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SEROPREVALENCE OF HEPATITIS B MARKERS
IN A RURAL COMMUNITY IN GHANA




Abstract: The seroprevalence of 2 hepatitis B virus markers, Hepatitis B surface antigen,
and Hepatitis B core antibody were determined in 731 blood donors, and 1020 pregnant
women in 3 hospitals in a rural community in Ghana during August 1991-July 1992 (blood
donors) and August-November 1992 (pregnant women) by an Enzyme Immunoassay
method. The prevalence of Hepatitis B surface antigen in the 2 groups was 19.5%, and 14%
respectively. That hepatitis B virus infection is endemic in the community is borne out by





1iver cirrhOSis，and primary hepatocel1u1ar carcinOma（PHCC）（Beas1ey etaL1981）．Its
preva1enceandmajOrmOdesOftransmissionvaryindifferentpartsOftheW0r1d・Inindustriai




1989），PreVa1ences Of6．20％have been repOrted．Other mOdes Of transmissiOninc1ude
transfusion Ofinfected b1OOd and heterOseXua1intercOurse．The efficiency Of HBV transmis－
sionthrOughb1OOdhasbeenestimatedat30％（CentersfOrDiseaseC0ntrO1，1985）．Itisim－
pOrtant therefore tO make a11transfusib1e b1OOd safe from HBVinfection．We repOrt the
preva1ence of Hepatitis B surface antigen（HBsAg）and tOtalHepatitis B cOre antibOdy
（HBcAb）in b1OOd dOnOrs and pregnant WOmen rePOrting to the Wa，J阜rapa and Mandom
Hospita1s，a11OfWhicharerura1cOmmunitiesintheUpperWestRegiOnOfGhana．
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reg10n aS eXp1ained previous1y・Chronic carr1age Of HBsAg from horizonta1transmissionin
Chi1drenfrom1argefami1iesp1ayingands1eepingtogetherinsma1iroomSduetOpOOrsO－
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cioeconomic conditions, with probable dissemination of saliva could be another factor. It is
difficult to estimate the relative contribution of these two factors. Perez et al (1989) studying
blood donors in Maputo, reported a prevalence of 18.6%
perinatal transmission of HBV from carrier mothers is important in determining the
prevalence of infection in some regions of the world. 14% of pregnant women had both
HBsAg and HBcAb serology in this study. These women together with the 143 blood donors,
even though not acutely ill or jaundiced, could potentially infect their babies･
The endemicity of HBV in this rural community is shown by the finding that out of the
total of 1751 subjects studied, 90% had serological evidence of present and/or past HBV in…
fection. A figure of 78.4% has been reported from Yaounde, Cameroun (Ndumbe and Njie,
1989).
Tropical Africa together with East and South East Asia and the Pacific Islands have
been designated high endemic areas of HBV infection (Centers for Disease Control, 1989).
These geographic areas have high incidences of PHCC, and patients with PHCC tend to be
HBsAg positive or have high titres of HBcAb (Zuckerman et al, 1990). Sixty per cent of
Acheampong's patients with PHCC were HBsAg positive (Acheampong, 1991). The contri-
bution of HBV to the development of PHCC can not be underestimated.
Hepatitis B is now a vaccine preventable disease. It is recommended that in areas of
intermediate to high endemicity and where transmission is primarily perinatal or child to
child, all infants should receive hepatitis B vaccine as pre-exposure prophylaxis (World Health
organisation, 1989). Where it can be afforded, maternal screening should be carried out
during pregnancy with the administration of hepatitis B vaccine and/or immunoglobulm to
infants of HBsAg mothers. In the Gambia, Hepatitis B vaccine has been integrated into the
National Expanded Programme on lmmunisation without major changes to the schedule of
immunisation or the mechanism of delivery (The Gambian Hepatitis Group, 1989). Serological
study of some of the vaccinated children has shown the strategy to be effective in reducing
the prevalence of persistently infected children (Whittle et al, 1995).
We have shown the endemicity of HBV infection in this rural community in Ghana.
Ghana, like some other developing countries has not introduced Hepatitis B vaccine as a
routine in the expanded programme on immunisation, due mostly to its cost. A closer look
needs to be taken at this.
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